EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The prevalence of tardive dyskinesia in a population of long term schizophrenic patients


Nervenarzt 57(2): 116-118
The prevalence of tardive dyskinesia in a population of long term schizophrenic patients
A population of long-term hospitalized schizophrenic patients (no. = 76) were studied for symptoms of tardive dyskinesia with the aid of the Abnormal Involuntary Movements scale. The prevalence rate was 25%. The direct influence of the potential risk factors age, sex, duration of treatment with neuroleptics, duration of hospitalization, treatment with electroshock therapy and treatment with anticholinergic agents, on the appearance of tardive dyskinesia were checked by means of discriminant and covariance analysis techniques. A statistically significant direct effect could only be established for duration of treatment with neuroleptics.


Accession: 006740526



Related references

Prevalence of tardive dyskinesia in long-term hospitalized schizophrenic patients. Der Nervenarzt 57(2): 116-118, 1986

Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment. International Journal of Geriatric Psychiatry 13(7): 473-479, 1998

Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: Prevalence and association with cognitive impairment. International Journal of Geriatric Psychiatry 13(7): 473-479, 1998

Tardive dyskinesia in long-term hospitalised Zulu psychiatric patients. A prevalence study. South African Medical Journal 71(2): 88-90, 1987

Tardive dyskinesia in long term hospitalized zulu psychiatric patients a prevalence study. South African Medical Journal 71(2): 88-90, 1987

Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia. Psychopharmacology 84(3): 436-440, 1984

Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population. Acta Psychiatrica Scandinavica 83(3): 234-237, 1991

The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients. Parkinsonism & Related Disorders 15(9): 655-659, 2010

An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study. Schizophrenia Research 77(2-3): 129-139, 2005

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Archives of General Psychiatry 50(9): 723-733, 1993